Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network
Study Supports the Need for Real-World Evidence to Better Manage CLL Patients
Videos
Study Supports the Need for Real-World Evidence to Better Manage CLL Patients
12/09/2020
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL...
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL...
Anthony Mato, MD, Memorial Sloan...
12/09/2020
Population Health
Benefits of Dual Treatment for MCL
Videos
Benefits of Dual Treatment for MCL
12/09/2020
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Constantine Tam, MD, director of...
12/09/2020
Population Health

Advertisement

First-Line Ibrutinib Treatment Shows Long-Term Efficacy, High PFS and OS Rates in CLL
Videos
First-Line Ibrutinib Treatment Shows Long-Term Efficacy, High PFS and OS Rates in CLL
12/06/2020
Based on a median follow-up of four years, John Allen, MD, assistant professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine, New York-Presbyterian Hospital, explains how first-line ibrutinib-based...
Based on a median follow-up of four years, John Allen, MD, assistant professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine, New York-Presbyterian Hospital, explains how first-line ibrutinib-based...
Based on a median follow-up of...
12/06/2020
Population Health
Study Shows Treatment Combo Beneficial for Patients With CLL
Videos
Study Shows Treatment Combo Beneficial for Patients With CLL
12/05/2020
William G. Wierda, MD, PhD, professor, Department of Leukemia, University of Texas MD Anderson Cancer Center, discusses the results of the Phase II CAPTIVATE study, and highlights how the use of Ibrutinib plus Venetoclax confers high rates of...
William G. Wierda, MD, PhD, professor, Department of Leukemia, University of Texas MD Anderson Cancer Center, discusses the results of the Phase II CAPTIVATE study, and highlights how the use of Ibrutinib plus Venetoclax confers high rates of...
William G. Wierda, MD, PhD,...
12/05/2020
Population Health
Preliminary Efficacy, Safety Identified for Treatment Option for Patients With Multiple Myeloma
Videos
Preliminary Efficacy, Safety Identified for Treatment Option for Patients With Multiple Myeloma
12/05/2020
Alfred L Garfall, MD, MS, assistant professor of Medicine, Perelman School of Medicine, University of Pennsylvania, discusses his recent study presented at ASH 2020, which examined the use of teclistamab for the treatment of multiple myeloma,...
Alfred L Garfall, MD, MS, assistant professor of Medicine, Perelman School of Medicine, University of Pennsylvania, discusses his recent study presented at ASH 2020, which examined the use of teclistamab for the treatment of multiple myeloma,...
Alfred L Garfall, MD, MS,...
12/05/2020
Population Health

Advertisement

Analyzing the Use of CAR-T Therapy for the Treatment of Multiple Myeloma
Videos
Analyzing the Use of CAR-T Therapy for the Treatment of Multiple Myeloma
12/05/2020
Deepu Madduri, MD, assistant professor, Hematology and Medical Oncology of the Mount Sinai Hospital, Mount Sinai Beth Israel, discusses the results of the CARTITUDE-1 study, which analyzed ciltacabtagene autoleucel, a CAR-T-cell therapy with...
Deepu Madduri, MD, assistant professor, Hematology and Medical Oncology of the Mount Sinai Hospital, Mount Sinai Beth Israel, discusses the results of the CARTITUDE-1 study, which analyzed ciltacabtagene autoleucel, a CAR-T-cell therapy with...
Deepu Madduri, MD, assistant...
12/05/2020
Population Health
Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck
Videos
Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck
11/17/2020
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...
Luca Marsili MD, PhD, Gardner...
11/17/2020
Annals of Long-Term Care
Discussing Treatment Paradigm Shifts, Successful Therapy Options for Atopic Dermatitis
Videos
Discussing Treatment Paradigm Shifts, Successful Therapy Options for Atopic Dermatitis
11/13/2020
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, describes challenges involved with treating atopic dermatitis, highlights the benefits of dupilumab—particularly among pediatric patients,...
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, describes challenges involved with treating atopic dermatitis, highlights the benefits of dupilumab—particularly among pediatric patients,...
Vivian Shi, MD, FAAD, associate...
11/13/2020
First Report Managed Care

Advertisement

Reviewing the Details of Pfizer’s COVID Vaccine and Understanding Future Implications of Care
Videos
Reviewing the Details of Pfizer’s COVID Vaccine and Understanding Future Implications of Care
11/12/2020
Eric Maroyka, PharmD, senior director, Center for Pharmacy Practice Advancement, ASHP, discusses the recent announcement from Pfizer regarding a successful COVID-19 vaccine, reviews the logistics of the vaccine, and highlights future...
Eric Maroyka, PharmD, senior director, Center for Pharmacy Practice Advancement, ASHP, discusses the recent announcement from Pfizer regarding a successful COVID-19 vaccine, reviews the logistics of the vaccine, and highlights future...
Eric Maroyka, PharmD, senior...
11/12/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

What's Trending?

News Connection
Azithromycin and Lung Function in Cystic Fibrosis
06/25/2010
A study published in the Journal of the American Medical Association has reported that a 24-week regimen of azithromycin therapy in children and adolescents with cystic fibrosis (CF) who were not infected with Pseudomonas aeruginosa did not...
A study published in the Journal of the American Medical Association has reported that a 24-week regimen of azithromycin therapy in children and adolescents with cystic fibrosis (CF) who were not infected with Pseudomonas aeruginosa did not...
A study published in the Journal...
06/25/2010
First Report Managed Care
News
Spectral Medical`s sepsis treatment fails late-stage study
10/03/2016
By Reuters Staff(Reuters) -...
By Reuters Staff(Reuters) -...
...
10/03/2016
Population Health
News
FDA Puts New Limits on Oral MS Drug
05/14/2012
05/14/2012
First Report Managed Care
News Connection
Novo Nordisk Pledges to Limit Drug Price Increases, Critics Respond
12/19/2016
In an effort to combat controversy over climbing prices, and hoping to simplify a complex system, Novo Nordisk has detailed a series of steps to ensure a “positive impact on affordability for patients,” according to a recent press release.
In an effort to combat controversy over climbing prices, and hoping to simplify a complex system, Novo Nordisk has detailed a series of steps to ensure a “positive impact on affordability for patients,” according to a recent press release.
In an effort to combat...
12/19/2016
First Report Managed Care
News
CMS Slashes 340B Payments to Hospitals
11/02/2017
The CMS announced it would significantly cut Medicare payments made to hospitals for drugs purchased under the 340B program.
The CMS announced it would significantly cut Medicare payments made to hospitals for drugs purchased under the 340B program.
The CMS announced it would...
11/02/2017
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use